ERBB2 and breast cancer: For instance, Lamp2b fused to αγ integrin-specific peptide iRGD and human epidermal growth factor receptor 2 (HER2)-binding affibody, showed improved EV tropism towards integrin-positive breast cancer cells and HER2-expressing tumour cells, respectively [47,72].